Literature DB >> 16774938

Increased frequency of disease-causing MYH mutations in colon cancer families.

Paolo Peterlongo1, Nandita Mitra, Ana Sanchez de Abajo, Miguel de la Hoya, Chiara Bassi, Lucio Bertario, Paolo Radice, Emily Glogowski, Khedoudja Nafa, Trinidad Caldes, Kenneth Offit, Nathan A Ellis.   

Abstract

The genetic factors that cause clustering of colorectal cancers (CRCs) other than mutations in the mismatch repair (MMR) genes are not well understood. Clustering in families who lack MMR gene mutations may be attributable to low-penetrance mutations. Hypothetically, mono-allelic MYH mutations could contribute to the risk of CRC in these families. Using Fisher's exact test and logistic regression, we compared the frequency of the known disease-causing MYH mutations Y165C, G382D and 466delE in 137 probands (117 cases with CRC and 20 cases diagnosed on the basis of adenomatous polyps only) from families with three or more CRCs but negative for mutations in the MMR genes and in 967 healthy controls with comparable ethnic backgrounds. Of 137 cases, 6 (4.4%) carried mono-allelic MYH mutations compared with 16 of 967 (1.6%) controls. In addition, three bi-allelic MYH mutation carriers, who eventually developed MYH-associated polyposis, were also identified in families with pedigree structures consistent with dominant inheritance of CRC susceptibility. By Fisher's exact tests, there was a statistically different frequency of cases with any MYH mutation (mono- or bi-allelic carriers; P-value = 0.002) and of cases with mono-allelic MYH mutation (P = 0.04) compared with the controls. Using a logistic regression model, the unadjusted odds ratio associated with any MYH mutation was 4.14 (P-value < 0.001); for mono-allelic carriers, it was 2.79 (P-value = 0.04). Adjusting for ethnic backgrounds, gender and age, the odds ratio associated with any disease-causing MYH mutation was 3.23 (P-value = 0.01); for mono-allelic carriers, it was 1.99 (P-value = 0.20). Overall, the results support previous studies suggesting that mono-allelic mutations of MYH constitute low-penetrance CRC-causing alleles. These data further support a model in which low-penetrance alleles are enriched in MMR gene mutation-negative CRC families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16774938     DOI: 10.1093/carcin/bgl093

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

1.  Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis.

Authors:  Aung Ko Win; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

2.  Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.

Authors:  Afaf Elsaid; Rami Elshazli; Fatma El-Tarapely; Hossam Darwish; Camelia Abdel-Malak
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 3.  Serrated pathway colorectal cancer in the population: genetic consideration.

Authors:  Joanne Young; Mark Jenkins; Susan Parry; Bruce Young; Derek Nancarrow; Dallas English; Graham Giles; Jeremy Jass
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

4.  New insights into the molecular pathogenesis of colorectal cancer.

Authors:  Kenneth E Hung; Daniel C Chung
Journal:  Drug Discov Today Dis Mech       Date:  2006

5.  Common MUTYH mutations and colorectal cancer risk in multiethnic populations.

Authors:  Flavio Lejbkowicz; Ilana Cohen; Ofra Barnett-Griness; Mila Pinchev; Jen Poynter; Stephen B Gruber; Gad Rennert
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

6.  Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil.

Authors:  Carlos E Pitroski; Silvia Liliana Cossio; Patrícia Koehler-Santos; Marcia Graudenz; João Carlos Prolla; Patricia Ashton-Prolla
Journal:  Int J Colorectal Dis       Date:  2011-03-22       Impact factor: 2.571

7.  Pathological features of colorectal carcinomas in MYH-associated polyposis.

Authors:  A M O'Shea; S P Cleary; M A Croitoru; H Kim; T Berk; N Monga; R H Riddell; A Pollett; S Gallinger
Journal:  Histopathology       Date:  2008-06-28       Impact factor: 5.087

8.  Proximal colon cancer in patients aged 51-60 years of age should be tested for microsatellites instability. A comment on the Revised Bethesda Guidelines.

Authors:  E Urso; S Pucciarelli; M Agostini; I Maretto; C Mescoli; R Bertorelle; A Viel; M Rugge; D Nitti
Journal:  Int J Colorectal Dis       Date:  2008-04-30       Impact factor: 2.571

9.  The signatures of autozygosity among patients with colorectal cancer.

Authors:  Manny D Bacolod; Gunter S Schemmann; Shuang Wang; Richard Shattock; Sarah F Giardina; Zhaoshi Zeng; Jinru Shia; Robert F Stengel; Norman Gerry; Josephine Hoh; Tomas Kirchhoff; Bert Gold; Michael F Christman; Kenneth Offit; William L Gerald; Daniel A Notterman; Jurg Ott; Philip B Paty; Francis Barany
Journal:  Cancer Res       Date:  2008-03-28       Impact factor: 12.701

10.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.